EVC
OME

Eidelman Virant Capital’s Omega Protein OME Stock Holding History

Eidelman Virant Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-45,579
Closed -$913K – 127
2017
Q1 		$913K Buy
+45,579
New +$1.06M 0.63% 50
2016
Q2 		– Sell
-130,000
Closed -$2.22M – 149
2016
Q1 		$2.22M Buy
+130,000
New +$2.66M 1.5% 20
2015
Q4 		– Sell
-64,000
Closed -$1.09M – 175
2015
Q3 		$1.09M Buy
+64,000
New +$996K 0.74% 45

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eidelman Virant Capital's OME Position: Q2 2017 in Review

Eidelman Virant Capital sold out of Omega Protein (OME) in Q2 2017, closing a stake of 45,579 shares — an estimated $913K sold.

Eidelman Virant Capital first reported a position in OME in Q3 2015 and held it in 3 quarters. The position peaked at $2.22M in Q1 2016. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

  • Eidelman Virant Capital reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
  • Eidelman Virant Capital sold 45,579 Omega Protein shares in Q2 2017, an estimated $913K.
  • Eidelman Virant Capital first reported a position in Omega Protein in Q3 2015 and held it in 3 quarters.
  • Eidelman Virant Capital's Omega Protein position peaked at $2.22M in Q1 2016.
  • 140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on Eidelman Virant Capital's 13F filing for Q2 2017, filed 26 Jul 2017.